In a stunning scientific discovery, researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice. And the best part of all?

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down. Researchers are now unraveling how these medications affect immune ...

A UCSF and Gladstone Institutes team discovered a pair of cancer drugs that successfully treated a model of severe Alzheimer’s disease. From left: Marina Sirota, PhD; Yaqiao Li, PhD; and Yadong Huang, ...

Scientists at UC San Francisco and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in the brain during Alzheimer's, potentially slowing or even ...

Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release ...

In a new study, colon cancer patients on these medications were more likely to make it to the 5-year survival mark than patients not on the drugs. In a new study, colon cancer patients who took GLP-1 ...

A new program at the FDA has sped up the review of three cancer drugs and may provide opportunities to accelerate review and approval for other oncology therapies even faster than the agency’s ...

Medicine is evolving—and quickly. With chronic diseases surging and scientific innovations accelerating, a new generation of best-selling medicines is revolutionizing the way we treat cancer, diabetes ...

As more continues to be understood about the health benefits associated with GLP-1 drugs, a growing body of science is aiming to answer whether the popular weight-loss medication can help with one of ...

Despite previous excitement around a potential link between GLP-1 drugs and a reduced risk of cancer, new research suggests the popular medications “probably have little or no effect” on a person’s ...

FDA reviewers flagged trial uncertainties for nearly 80% of cancer drugs approved from 2019 to 2022, but few were reported in journals or National Comprehensive Cancer Network (NCCN) guidelines. The ...

If you’ve ever thought about taking GLP-1 drugs like Ozempic, you might have been scared off by the possibility of thyroid cancer. Recent research, however, finds that this potential danger could ...